Long-Term Debt: The sum of all long term debt fields.
Ernexa Therapeutics Inc. (ERNA) Long-Term Debt data is not available for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
$-1.51M |
|
-- |
|
-- |
|
$2.10M |
|
$-2.10M |
|
$0.53M |
|
$-1.56M |
|
$-1.56M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-1.50M |
|
$-2.10M |
|
$-2.03M |
|
6.31M |
|
6.31M |
|
$0.77 |
|
$0.77 |
|
| Balance Sheet Financials | |
$3.13M |
|
$0.09M |
|
$2.70M |
|
$5.83M |
|
$3.11M |
|
|
Long-Term Debt |
-- |
$0.32M |
|
$3.43M |
|
$2.40M |
|
$0.36M |
|
$2.40M |
|
7.85M |
|
| Cash Flow Statement Financials | |
$-7.02M |
|
$-0.04M |
|
$7.21M |
|
$1.73M |
|
$1.88M |
|
$0.15M |
|
$1.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.05M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-62.63% |
|
-421.01% |
|
-25.76% |
|
-62.60% |
|
$0.31 |
|
$-1.12 |
|
$-1.11 |
|